Olga Alexandrovna Chikulaeva

Olga Alexandrovna Chikulaeva

Auto-generated profile, based on publicly available information

Olga Alexandrovna Chikulaeva

Endocrinology Research Centre

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2021 in Clinical and experimental thyroidology
Verified
Journal Article
Open access
PDF file
VPValentina Peterkova
Valentina Peterkova
OBOlga Bezlepkina
Olga Bezlepkina
ENE. V. Nagaeva
E. V. Nagaeva
TST. Y. Shiryaeva
T. Y. Shiryaeva
OCO. A. Chikulaeva
O. A. Chikulaeva
NBN. V. Bolotova
N. V. Bolotova
The thyroiditis in children are urgent problem of pediatric endocrinology due to the widespread occurrence and characterized by clinical and pathogenetic heterogeneity. The developed clinical guidelines are the main working tool of the practitioner. They briefly and structurally present the main information about the epidemiology and modern classification of thyroiditis, methods of their diagnosis and treatment based on the principles of evidence-based medicine.

23 August 2018 in Clinical and experimental thyroidology
Verified
Journal Article
Open access
PDF file
NMNina Makretskaya
Nina Makretskaya
OBOlga Bezlepkina
Olga Bezlepkina
AKAnna A. Kolodkina
Anna A. Kolodkina
AKAlexey V. Kiyaev
Alexey V. Kiyaev
EVEvgeny Vasilyev
Evgeny Vasilyev
ВВВасильев Евгений Витальевич
Васильев Евгений Витальевич
Congenital hypothyroidism is a heterogeneous group of diseases, which is manifested by loss of function of the thyroid gland that affects infants from birth. 80–85% of cases are due to different types of thyroid dysgenesis. 5 genes have been described that are involved in the pathogenesis of thyroid dysgenesis: TSHR, PAX8, FOXE1, NKX2-1, NKX2-5. Aims. To evaluate the prevalence of mutations in the genes TSHR, PAX8, FOXE1, NKX2-1, NKX2-5 among patients with severe congenital hypothyroidism. Materials and methods. 161 patients (64 boys, 97 girls) with congenital hypothyroidism (TSH levels at neonatal screening or retesting greater than 90 mU/l) were included in the study. 138 subjects had different variants of thyroid dysgenesis, and 23 patients had normal volume of the gland. A next generation sequencing was used for molecular-genetic analysis. Sequencing was performed using PGM semiconductor sequencer (Ion Torrent, Life Technologies, USA) and a panel “Hypothyroidism” (Custom DNA Panel). Assessment of the pathogenicity of sequence variants were carried out according to the latest international guidelines (ACMG, 2015). Results. 13 patients had variants in thyroid dysgenesis genes (8,1%, 13/161): TSHR, n = 6; NKX2-1, n = 3; NKX2-5, n = 1; PAX8, n = 3; FOXE1, n = 0. Conclusions. Mutations in thyroid dysgenesis genes are a rare pathology. The majority of variants among our patients were identified in TSHR.

24 December 2016 in Endocrine Surgery
Verified
Journal Article
Open access
PDF file
PRPavel Olegovich Rumiantsev
Pavel Olegovich Rumiantsev
AKAlexey Vasil'EVich Kiyaev
Alexey Vasil'EVich Kiyaev
MSMarina Sergeevna Sehemeta
Marina Sergeevna Sehemeta
OCOlga Alexandrovna Chikulaeva
Olga Alexandrovna Chikulaeva
Болезнь Грейвса (БГ) – основная причина тиреотоксикоза у детей. В современной клинической практике применяется три метода лечения БГ: тиреостатики, радиоактивный йод и операция. Все эти методы лечения применяются давно, и в мире накоплен огромный опыт применения каждого из методов лечения. Лечение начинают практически всегда с тиреостатиков, непереносимость или неэффективность которых становится показанием к выбору альтернативных методов лечения. Для осознанного выбора метода лечения необходимо понимать его потенциальные параметры эффективности и безопасности, а также влияющие на них факторы. Цель обзора – критический анализ эффективности и безопасности радиойодтерапии в лечении тиреотоксикоза у детей и подростков в сравнении с аналогичными показателями других методов лечения, а также показания и противопоказания к данному виду лечения в современной клинической практике эндокринологов, радиологов и эндокринных хирургов. Выбор тактики лечения БГ у ребенка на каждом этапе осуществляется согласованно с ним и его родителями/опекунами путем информирования лечащим врачом об объективных преимуществах и недостатках методов лечения на основе имеющейся доказательной базы. Также приведены основные рекомендации эффективной и безопасной терапии радиоактивным йодом БГ у детей и подростков.

7 July 2017 in Clinical and experimental thyroidology
Verified
Journal Article
Open access
PDF file
PRPavel O. Rumiantsev
Pavel O. Rumiantsev
MSMarina S. Sheremeta
Marina S. Sheremeta
AKAlexey V. Kiyaev
Alexey V. Kiyaev
LKLuydmila A. Kurmyshova
Luydmila A. Kurmyshova
OCOlga A. Chikulaeva
Olga A. Chikulaeva
КВКияев Алексей Васильевич
Кияев Алексей Васильевич
There are three methods in treatment of Graves’ disease in children and adolescents – antithyroid drugs, surgery and radioiodine therapy (RIT). However, treatment protocol of children and adolescents doesn’t exist. In the present case series study we have evaluated the effectiveness and safety of RIT in children and adolescents. We have observed totally 25 patients in age 11–17 years old (mean 14.8 years) with Graves’ disease. Ten patients were treated with RIT in Endocrinology Research Centre (Moscow) in 2016 year with activities 550–920 MBq. Follow-up period varied 6–11 months in this subgroup. The second subgroup (15 patients) was treated in radiology department in Nijniy Tagil rural hospital (Ural region) in the period 2005–2012 years. Follow-up period varied 3.5–11.5 years (mean 8.5 years). RIT was executed in all patients without any complications, direct or long-term. In two patients having endocrine ophtalmopathy in non-active phase it was no any signs of worsening in result of RIT. In 17 (68%) of 25 patients the hypothyroidism occurred through 6 months. In one case – euthyroidism. In remain 7 observations the hyperthyroidism recurred. Patient subgroups didn’t differ in mean age, gender ratio, thyroid size and autoantibodies to TSH receptor levels, but were differed in treatment 131I activities (subset from ERC – 550–920 MBq; subset from Nijniy Tagil – 168–400 MBq). However the treatment efficacy did not differ significantly (p = 0.99): 68% and 73%, accordingly. In conclusion, RIT of Graves’ disease in a safe and effective method of treatment for hyperthyroidism in children and adolescents. It’s necessary to prolong study in numerous patients cohort, longer-lasting follow-up period as well as to improve RIT efficiency.

4 May 2017 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
NMNina Makretskaya
Nina Makretskaya
OBOlga Bezlepkina
Olga Bezlepkina
OCOlga A. Chikulaeva
Olga A. Chikulaeva
EVEvgeny Vasilyev
Evgeny Vasilyev
VPVasiliy M. Petrov
Vasiliy M. Petrov
ТНТюльпаков Анатолий Николаевич
Тюльпаков Анатолий Николаевич
Congenital hypothyroidism is a genetically heterogeneous group of diseases caused by two mechanisms: gland dysgenesis and dyshormonogenesis. The disease pattern includes a number of syndromic forms, one of which is a combination of congenital hypothyroidism and sensorineural hearing loss (Pendred syndrome) initially associated with SLC26A4 gene defects. The article describes a patient with clinical manifestations of Pendred syndrome who was diagnosed with a TPO gene defect during a molecular genetic analysis using next generation sequencing (NGS). Therefore, a combination of congenital hypothyroidism and sensorineural hearing loss can have a different molecular basis. Our findings illustrate the value of NGS for genetic verification of the diagnosis.

17 September 2024 in Clinical and experimental thyroidology
Verified
Journal Article
Open access
PDF file
VPValentina Peterkova
Valentina Peterkova
OBOlga Bezlepkina
Olga Bezlepkina
TST. U. Shiryaeva
T. U. Shiryaeva
ENE. V. Nagaeva
E. V. Nagaeva
TVT. A. Vadina
T. A. Vadina
ICI. S. Chugunov
I. S. Chugunov
Thyroiditis in children are important issues of pediatric endocrinology due to their widespread occurrence. They differ in etiology, pathogenesis, and their clinical manifestations. Updated clinical guidelines in 2024 are the main working tool of physicians. They briefly and structurally present the main information about epidemiology and modern classification of thyroiditis, methods of diagnosis and treatment based on the principles of evidence-based medicine.